萬超教授 - 生物醫學學院

萬超教授

副教授

MBBS, MS, Ph.D.

39434494

cwan@cuhk.edu.hk

Rm 128A, Lo Kwee-Seong Integrated Biomedical Sci. Bldg, CUHK

Publons

ORCID

個人簡介

Prof. WAN Chao (萬超) is an Associate Professor in School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong (CUHK). He serves as a Co-Director of the MOE Key Laboratory of Regenerative Medicine, and CUHK-University of Southampton Joint Laboratory for Stem Cell and Regenerative Medicine. He is a member of the Institute for Tissue Engineering and Regenerative Medicine and an associate member in the Department of Biomedical Engineering, CUHK, and a member in the InnoHK CNRM. Dr. Wan obtained his Ph.D. in Shanghai Jiao Tong University School of Medicine, then worked as a resident Orthopaedic Surgeon in Longhua Hospital, Shanghai University of Traditional Chinese Medicine. He pursued postdoctoral training in School of Medicine, The Queen’s University of Belfast, UK, and in School of Medicine, University of Alabama at Birmingham (UAB), USA. He was then appointed as an Instructor in Department of Pathology, UAB, and an Instructor in Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine. Prof. Wan’s research interests include the molecular and cellular mechanisms of the oxygen sensing and growth factor pathways in skeletal development, degeneration and regeneration, and discovery of novel therapies for skeletal tissue repair or regeneration. His research work has been published in international journals including Proc Natl Acad Sci USA, J Clin Invest, Nat Med, Cell, Bone Res, Biomaterials, and Int J Bioprint. He was a recipient of British Orthopaedic Research Society Travelling Award, ICMRS Webster Jee Young Investigator Award, and ASBMR Harold Frost Young Investigator Award. He serves as an editorial board member and reviewer for multiple journals in the field. His research work was supported by Hong Kong Research Grants Council, Health and Medical Research Fund, Innovation and Technology Commission, National Natural Science Foundation of China and Ministry of Science and Technology. He serves as a founder of a startup company and his translational work aims to facilitate the application of novel technologies to benefit the patients with skeletal disorders.

研究興趣

Molecular and cellular mechanisms of skeletal development, metabolism and regeneration.
Molecular control of stem cell self-renewal and mesenchymal lineage differentiation.
Tissue engineering for skeletal tissue repair.
Efficacy and novel therapeutics of Chinese medicines for skeletal tissue repair.

著作選錄

Zhou, Z., Zhang, F., Wan, C. (2025). Biomechanically inspired composite hydrogel bioink enhances engineered cartilage formation. Int J Bioprint, 2, 5230.
Zhang, H., Zhou, Z., Zhang, F., & Wan, C. (2024). Hydrogel-based 3D bioprinting technology for articular cartilage regenerative engineering. Gels, 10(7), 430.
He, Q., Shi, L., Luo, Y., Wan, C., Malone, I.B., Mok, V.C., Cole, J.H., Anatürk, M. (2022). Validation of the AD-RAI in classifying and predicting progression in Alzheimer’s Disease. Front Aging Neurosci., 14, 932125.
Huang J, U KP, Yang F, Ji Z, Lin J, Weng Z, Tsang LL, Merson TD, Ruan YC, Wan C., Li G, & Jiang, X. (2022). Human pluripotent stem cell-derived ectomesenchymal stromal cells promote more robust functional recovery than umbilical cord-derived mesenchymal stromal cells after hypoxic-ischaemic brain damage. Theranostics, 12(1), 143-166.
Wan, C., Zhang, F., Yao, H., Li, H., Tuan, R.S. (2021). Histone Modifications and Chondrocyte Fate: Regulation and Therapeutic Implications. Front Cell Dev Biol, 9:626708.
Yu, L., Xie, M., Zhang, F., Wan, C., Yao, X. (2021). TM9SF4 is a novel regulator in lineage commitment of bone marrow mesenchymal stem cells to either osteoblasts or adipocytes. Stem Cell Res Ther, 12(1):573.
Tu, J., Wan, C., Zhang F., Cao, L., Law, W.L.P., Tian, Y., Lu, G., Rennert, M.O., Chan, W.Y., Cheung, H.H. (2020). Genetic correction of Werner syndrome gene reveals impaired pro-angiogenic function and HGF insufficiency in mesenchymal stem cells. Aging cell, 19(5), e13116 pgs.
Yang, Z., Kou, S., Wei, X., Zhang, F., Li, F., Wang, X., Lin, Y., Wan, C., Zhang, W., & Sun, F. (2018). Genetically Programming Stress-Relaxation Behavior in Entirely Protein-Based Molecular Networks. ACS Macro Letters, 7(12), 1468-1474. doi: 10.1021/acsmacrolett.8b00845
Wang, J., Zhang, F., Tsang, W.P., Wan, C., & Wu, C. (2017). Fabrication of injectable high strength hydrogel based on 4-arm star PEG for cartilage tissue engineering. Biomaterials, 120, 11-21.
Tsang, W. P., Zhang, F., He, Q., Cai, W., Huang, J., Chan, W.Y., Shen, Z., & Wan, C. (2017). Icaritin enhances mESC self-renewal through upregulating core pluripotency transcription factors mediated by ERα. Sci Rep, 7, 40894.
He, Q., Swindle, C.S., Wan, C., Flynn, R.J., Oster, R.A., Chen, D., Zhang, F., Shu, Y., & Klug, C.A. (2017). Enhanced hematopoietic stem cell self-renewal-promoting ability of clonal primary MSC versus their osteogenic progeny. Stem Cells, 35(2), 473-484.
Wang, P.Z., Zhang, F., Shu, Y., Shiu, H.T., He, Q., Tsang, W. P., & Wan, C. (2016). Flavonoid compound Icariin activates hypoxia inducible factor-1α in chondrocytes and promotes articular cartilage repair. PLoS One, 11(2), e0148372.
Chen, X., Gu, S., Chen, B.F., Shen, W.L., Yin, Z., Xu, G. W., Hu, J.J., Zhu, T., Li, G., Ouyang, H.W., Wan, C., Lee, T.L., & Chan, W.Y. (2015). Nanoparticle delivery of stable miR-199a-5p agomir improves the osteogenesis of human mesenchymal stem cells via the HIF1a pathway. Biomaterials, 53, 239-250.
Tian, Y., Xu, Y., Fu, Q., Chang, M., Wang, Y., Shang, X., Wan, C., Marymont, J.V., & Dong, Y. (2015). Notch inhibits chondrogenic differentiation of mesenchymal progenitor cells by targeting Twist1. Mol Cell Endocrinol, 403C, 30-38.
Su, X., Zuo, W., Wu, Z., Chen, J., Wu, N., Ma, P., Xia, Z., Jiang, C., Ye, Z., Liu, S., Liu, J., Zhou, G., Wan, C., & Qiu, G. (2015). CD146 as a new marker for an increased chondroprogenitor cell sub-population in the later stages of osteoarthritis. J Orthop Res, 33(1), 84-91.
Zhang, F., He, Q., Tsang, W.P., Garvey, W.T., Chan, W.Y., & Wan, C. (2014). Insulin exerts direct, IGF-1 independent actions in growth plate chondrocytes. Bone Research, 2(2), 14012.
Wan, L., Zhang, F., He, Q., Tsang, W. P., Lu, L., Li, Q., Liu, Z., Qiu, G., Zhou, G., & Wan, C. (2014). EPO promotes bone repair through enhanced cartilaginous callus formation and angiogenesis. PLoS One, 9(7), e102010.
Meng, F., Rui, Y., Xu, L., Wan, C., Jiang, X., & Li, G. (2014). Aqp1 enhances migration of bone marrow mesenchymal stem cells through regulation of FAK and β-catenin. Stem Cells Dev, 2014, 23(1), 66-75.
Tsang, W. P., Shu, Y., Kwok, P.L., Zhang, F., Lee, K.K.H., Tang, M.K., Li, G., Chan, K.M., Chan, W.Y., & Wan, C. (2013). CD146 human umbilical cord perivascular cells maintain stemness under hypoxia and as a cell source for skeletal regeneration. PLoS One, 8(10), e76153.
Zhang, W., Shen, X., Wan, C., Zhao, Q., Zhang, L., Zhou, Q., & Deng, L. (2012). Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation: differential signalling via Akt and ERK. Cell Biochem Funct, 30(4), 297-302.
Wan, C., Shao, J., Gilbert, S.R., Riddle, R.C., Long, F., Johnson, R.S., Schipani, E., & Clemens, T.L. (2010). Role of HIF-1a in skeletal development. Ann N Y Acad Sci, 1192(1), 322-326.
Fulzele, K., Riddle, R.C., Digirolamo, D.J., Cao, X., Wan, C., Chen, D., Faugere, M.C., Aja, S., Hussain, M.A., Brüning, J.C., & Clemens, T.L. (2010). Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell, 142(2), 309-319.
Kumar, S., Wan, C., Ramaswamy, G., Clemens, T.L., & Ponnazhagan, S. (2010). Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. Mol Ther, 18(5), 1026-1034.
Tang, Y., Wu, X., Lei, W., Pang, L., Wan, C., Shi, Z., Zhao, L., Nagy, T.R., Peng, X., Hu, J., Feng, X., Van Hul W., Wan, M., & Cao, X. (2009). TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med, 15(7), 757-765.
Zhang, F., Shi, W., Qiu, T., Wu, X., Wan, C., Wang, Y., Wan, M., Clemens, T.L., & Cao, X. (2009). Sustained BMP signaling in osteoblasts stimulates bone formation by promoting angiogenesis and osteoblast differentiation. J Bone Miner Res, 2009, 24(7), 1224-1233.
Shen, X., Wan, C., Ramaswamy, G., Mavalli, M., Wang, Y., Duvall, C.L., Deng, L.F., Guldberg, R.E., Eberhart, A., Clemens, T.L., & Gilbert, S.R. (2009). Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice. J Orthop Res, 2009, 27(10), 1298-1305.
Jacobsen, K.A., Alaql, Z. S., Wan, C., Jennifer, L., Fitch, B.S., Mason, Z.D., Cole, R.M., Gilbert, S.R., Clemens, T.L., Morgan, E.F., Einhorn, T.A., & Gerstenfeld, L.C. (2008). Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signaling. J Bone Miner Res, 23(5), 596-609.
Wan, C., Gilbert, S.R., Wang, Y., Cao, X.M., Shen, X., Ramaswamy, G., Jacobsen, K.A., Alaql, Z.S., Gerstenfeld, L.C., Einhorn, T.A., Guldberg, R.E., Deng, L., & Clemens, T.L. (2008). Activation of the hypoxia inducible factor pathway accelerates bone regeneration. Proc Natl Acad Sci USA, 105(2), 686-691.
Wang, Y., Wan, C., Deng, L., Liu, X., Cao, X., Gilbert, S.R., Bouxsein, M.L., Faugere, M.C., Guldberg, R.E., Gerstenfeld, L.C., Haase, V.H., Johnson, R.S., Schipani, E., & Clemens, T.L. (2007). The hypoxia inducible factor pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest, 117(6), 1616-1626.
Liu, X., Bruxvoort, K., Zylstra, C.R., Liu, J., Cichowski, R., Faugere, M.C., Bouxsein, M.L., Wan, C., Williams, B.O., & Clemens, T.L. (2007). Lifelong accumulation of bone in mice lacking PTEN in osteoblasts. Proc Natl Acad Sci USA, 104(7), 2259-2264.